 Curtis Henry
Concepts (120)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 4 | 2022 | 269 | 1.080 |
Why?
| | Aging | 4 | 2021 | 1635 | 1.010 |
Why?
| | Burkitt Lymphoma | 2 | 2023 | 52 | 1.000 |
Why?
| | Leukemia | 4 | 2023 | 207 | 0.980 |
Why?
| | Hematopoiesis | 2 | 2017 | 175 | 0.900 |
Why?
| | Interleukin-12 | 4 | 2022 | 110 | 0.880 |
Why?
| | Galectins | 1 | 2022 | 22 | 0.810 |
Why?
| | Cell- and Tissue-Based Therapy | 1 | 2021 | 57 | 0.720 |
Why?
| | Precursor Cells, B-Lymphoid | 2 | 2017 | 34 | 0.660 |
Why?
| | Fusion Proteins, bcr-abl | 2 | 2015 | 61 | 0.600 |
Why?
| | Dendritic Cells | 3 | 2022 | 438 | 0.580 |
Why?
| | Folic Acid Deficiency | 1 | 2017 | 48 | 0.580 |
Why?
| | Folic Acid | 1 | 2017 | 159 | 0.550 |
Why?
| | Interleukin-1 | 1 | 2021 | 971 | 0.550 |
Why?
| | Cell Transformation, Neoplastic | 2 | 2015 | 312 | 0.520 |
Why?
| | Cytokines | 5 | 2023 | 1858 | 0.500 |
Why?
| | Proto-Oncogene Proteins c-myc | 1 | 2015 | 115 | 0.490 |
Why?
| | Dietary Supplements | 1 | 2017 | 460 | 0.450 |
Why?
| | Genetic Fitness | 2 | 2011 | 54 | 0.450 |
Why?
| | Interleukin-23 | 2 | 2010 | 15 | 0.440 |
Why?
| | Adenoma | 1 | 2015 | 187 | 0.440 |
Why?
| | Mice, Transgenic | 6 | 2021 | 1971 | 0.420 |
Why?
| | Listeria monocytogenes | 2 | 2010 | 110 | 0.400 |
Why?
| | Inflammation Mediators | 1 | 2015 | 480 | 0.400 |
Why?
| | Mice | 14 | 2023 | 15085 | 0.400 |
Why?
| | CD8-Positive T-Lymphocytes | 5 | 2023 | 688 | 0.380 |
Why?
| | Lymphopoiesis | 1 | 2010 | 24 | 0.370 |
Why?
| | Hematopoietic Stem Cells | 2 | 2010 | 356 | 0.360 |
Why?
| | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2023 | 66 | 0.360 |
Why?
| | Mice, Inbred BALB C | 4 | 2021 | 1169 | 0.350 |
Why?
| | Listeriosis | 1 | 2010 | 60 | 0.340 |
Why?
| | Obesity | 1 | 2022 | 2523 | 0.340 |
Why?
| | Interleukin-12 Subunit p35 | 1 | 2008 | 3 | 0.330 |
Why?
| | Chemokine CCL17 | 1 | 2008 | 5 | 0.330 |
Why?
| | Chemokine CCL1 | 1 | 2008 | 2 | 0.330 |
Why?
| | Interleukin-12 Subunit p40 | 1 | 2008 | 7 | 0.330 |
Why?
| | Biomarkers, Tumor | 1 | 2015 | 1045 | 0.320 |
Why?
| | Colorectal Neoplasms | 1 | 2015 | 617 | 0.310 |
Why?
| | Animals | 15 | 2023 | 32158 | 0.300 |
Why?
| | Adjuvants, Immunologic | 1 | 2008 | 206 | 0.290 |
Why?
| | Tumor Microenvironment | 4 | 2023 | 424 | 0.290 |
Why?
| | Lymphocyte Activation | 2 | 2019 | 1056 | 0.280 |
Why?
| | Stem Cells | 1 | 2010 | 546 | 0.270 |
Why?
| | Mice, Inbred C57BL | 6 | 2021 | 4779 | 0.250 |
Why?
| | Proto-Oncogene Proteins c-ets | 1 | 2022 | 51 | 0.200 |
Why?
| | Hematologic Neoplasms | 1 | 2023 | 135 | 0.200 |
Why?
| | Germ-Line Mutation | 1 | 2022 | 134 | 0.190 |
Why?
| | Antibodies, Bispecific | 1 | 2020 | 33 | 0.180 |
Why?
| | Cell Line, Tumor | 3 | 2022 | 2749 | 0.180 |
Why?
| | Bone Marrow | 2 | 2022 | 248 | 0.160 |
Why?
| | Calcineurin | 1 | 2019 | 84 | 0.160 |
Why?
| | Inflammation | 3 | 2022 | 2502 | 0.160 |
Why?
| | c-Mer Tyrosine Kinase | 1 | 2018 | 43 | 0.160 |
Why?
| | Metabolism | 1 | 2017 | 36 | 0.150 |
Why?
| | Nitriles | 1 | 2018 | 152 | 0.140 |
Why?
| | Nucleotides | 1 | 2017 | 113 | 0.140 |
Why?
| | Programmed Cell Death 1 Receptor | 1 | 2018 | 193 | 0.140 |
Why?
| | NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2018 | 145 | 0.140 |
Why?
| | Inflammasomes | 1 | 2018 | 116 | 0.140 |
Why?
| | Stem Cell Niche | 1 | 2015 | 43 | 0.130 |
Why?
| | Cell Line | 1 | 2021 | 2657 | 0.130 |
Why?
| | Cells, Cultured | 3 | 2018 | 3914 | 0.120 |
Why?
| | Anti-Inflammatory Agents | 1 | 2018 | 447 | 0.120 |
Why?
| | Macrophages | 2 | 2018 | 1282 | 0.120 |
Why?
| | Humans | 12 | 2023 | 115859 | 0.110 |
Why?
| | Mutation | 3 | 2022 | 3371 | 0.110 |
Why?
| | Mice, Knockout | 2 | 2010 | 2608 | 0.110 |
Why?
| | Protein Kinase Inhibitors | 1 | 2018 | 789 | 0.110 |
Why?
| | Apoptosis | 1 | 2022 | 2377 | 0.110 |
Why?
| | T-Lymphocytes | 1 | 2020 | 1758 | 0.110 |
Why?
| | Interleukin-7 | 1 | 2010 | 44 | 0.090 |
Why?
| | Immunotherapy, Active | 1 | 2010 | 8 | 0.090 |
Why?
| | Immunologic Factors | 2 | 2023 | 219 | 0.090 |
Why?
| | Antineoplastic Agents | 1 | 2020 | 1891 | 0.090 |
Why?
| | Bone Marrow Transplantation | 1 | 2010 | 241 | 0.080 |
Why?
| | Neoplasms | 1 | 2023 | 2114 | 0.080 |
Why?
| | Oncogenes | 1 | 2009 | 104 | 0.080 |
Why?
| | Immunity, Cellular | 1 | 2010 | 263 | 0.080 |
Why?
| | Immunologic Memory | 1 | 2010 | 312 | 0.080 |
Why?
| | Case-Control Studies | 1 | 2015 | 3054 | 0.080 |
Why?
| | Female | 5 | 2021 | 60070 | 0.070 |
Why?
| | Evolution, Molecular | 1 | 2011 | 442 | 0.070 |
Why?
| | Cell Communication | 1 | 2008 | 280 | 0.070 |
Why?
| | Immunotherapy | 2 | 2020 | 481 | 0.060 |
Why?
| | Up-Regulation | 1 | 2008 | 824 | 0.060 |
Why?
| | Immunity, Innate | 1 | 2011 | 735 | 0.060 |
Why?
| | Interferon-gamma | 1 | 2008 | 733 | 0.060 |
Why?
| | Male | 4 | 2021 | 56103 | 0.060 |
Why?
| | Cohort Studies | 1 | 2015 | 4960 | 0.060 |
Why?
| | Sialic Acid Binding Immunoglobulin-like Lectins | 1 | 2023 | 5 | 0.060 |
Why?
| | Prospective Studies | 1 | 2015 | 6276 | 0.060 |
Why?
| | CD4-Positive T-Lymphocytes | 2 | 2019 | 967 | 0.050 |
Why?
| | Immunoglobulins | 1 | 2023 | 148 | 0.050 |
Why?
| | Thrombopoiesis | 1 | 2022 | 6 | 0.050 |
Why?
| | Germ Cells | 1 | 2022 | 62 | 0.050 |
Why?
| | Adaptive Immunity | 1 | 2023 | 157 | 0.050 |
Why?
| | CD3 Complex | 1 | 2020 | 92 | 0.040 |
Why?
| | Antigens, CD19 | 1 | 2020 | 97 | 0.040 |
Why?
| | Repressor Proteins | 1 | 2022 | 369 | 0.040 |
Why?
| | Tumor Escape | 1 | 2019 | 35 | 0.040 |
Why?
| | Polymers | 1 | 2023 | 464 | 0.040 |
Why?
| | Gene Knockdown Techniques | 1 | 2019 | 303 | 0.040 |
Why?
| | Polyethylene Glycols | 1 | 2023 | 576 | 0.040 |
Why?
| | Signal Transduction | 1 | 2010 | 4527 | 0.040 |
Why?
| | Forkhead Transcription Factors | 1 | 2018 | 170 | 0.040 |
Why?
| | Caspase 1 | 1 | 2018 | 141 | 0.040 |
Why?
| | Membrane Proteins | 1 | 2023 | 1033 | 0.040 |
Why?
| | Gene Deletion | 1 | 2018 | 356 | 0.040 |
Why?
| | Aged | 1 | 2015 | 19292 | 0.040 |
Why?
| | Interleukin-18 | 1 | 2018 | 222 | 0.030 |
Why?
| | RNA | 1 | 2022 | 820 | 0.030 |
Why?
| | Monocytes | 1 | 2018 | 504 | 0.030 |
Why?
| | Interleukin-1beta | 1 | 2018 | 370 | 0.030 |
Why?
| | B-Lymphocytes | 1 | 2020 | 771 | 0.030 |
Why?
| | Middle Aged | 1 | 2015 | 27078 | 0.030 |
Why?
| | Lipopolysaccharides | 1 | 2018 | 832 | 0.030 |
Why?
| | Disease Progression | 1 | 2019 | 2423 | 0.030 |
Why?
| | DNA Damage | 1 | 2009 | 356 | 0.020 |
Why?
| | Reactive Oxygen Species | 1 | 2009 | 550 | 0.020 |
Why?
| | Child | 1 | 2023 | 18537 | 0.010 |
Why?
|
|
Henry's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|